SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Heart Attacks, Cancer and strokes. Preventative approaches
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ig who wrote (37860)6/17/2022 3:13:02 PM
From: bruwin1 Recommendation

Recommended By
Winfastorlose

  Read Replies (2) of 39342
 
If you haven't already seen it, you may want to watch this video. Dr. John Campbell explains how the very safe and inexpensive IVERMECTIN, a Protease Inhibitor, overcomes the COVID-19 virus .....



As it happens, PFIZER have come up with their own Protease Inhibitor, PAXLOVID. But that, not surprisingly, is Very Expensive seeing as it's "Under License". The Biden Administration has paid PFIZER $5.9 Billion for 10 Million treatment courses of PAXLOVID .......

And this is how the Northern States of India distributed IVERMECTIN to its citizens .....



Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News